Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,278Revenue $M2,175Net Margin (%)4.7Altman Z-Score4.3
Enterprise Value $M4,182EPS $3.1Operating Margin %7.7Piotroski F-Score6
P/E(ttm)42.2Beneish M-Score-2.7Pre-tax Margin (%)6.7Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %7.3Quick Ratio2.9Cash flow > EarningsY
Price/Sales2.05-y EBITDA Growth Rate %-3.9Current Ratio4.1Lower Leverage y-yN
Price/Free Cash Flow39.2y-y EBITDA Growth Rate %0.7ROA % (ttm)3.0Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)4.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.1ROIC % (ttm)5.7Gross Margin Increase y-yN

Gurus Latest Trades with BIO.B

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BIO.B is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BIO.B: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Magni GiovanniEVP, Chief Strategy Officer 2014-12-12Sell5,000$117.3825.08 view
SODERBERG SHAWN MARIEEVP, General Counsel, Sec 2014-12-03Sell83$12022.35 view
HERTIA JOHNExecutive Vice President 2014-11-25Sell6,000$119.3922.98 view
TSINGOS CHRISTINE AEVP and CFO 2014-11-20Sell1,326$115.8526.73 view
GOETZ JOHNEVP, COO 2014-11-19Sell4,891$114.4128.33 view
HUTTON RONALD WVice President and Treasurer 2014-11-13Sell3,066$111.6231.54 view
SCHWARTZ STEVEN D10% Owner 2014-11-13Sell530$111.9331.17 view
TSINGOS CHRISTINE AEVP and CFO 2014-11-12Sell7,000$112.2230.83 view
STARK JAMES RVP, Corporate Controller 2014-11-11Sell4,257$112.630.39 view

Press Releases about BIO.B :

Quarterly/Annual Reports about BIO.B:

    News about BIO.B:

    Articles On GuruFocus.com
    Bio-Rad Announces FDA Clearance for Diagnosing Diabetes With Its VARIANT II TURBO HbA1c Kit - 2.0 Jun 09 2015 
    Bio-Rad Laboratories Resolves Foreign Corrupt Practices Act Matters With U.S. Government Nov 03 2014 
    Bio-Rad to Report Third-Quarter 2014 Financial Results Tuesday, November 4, 2014 Oct 15 2014 
    Bio-Rad Appoints John Goetz as Chief Operating Officer and Announces Other Executive Appointments Oct 15 2014 
    Widely Held Guru Stocks Near Historical Low P/B Ratios Aug 11 2014 
    Guru Held Stocks Near Historical Low P/B Jul 22 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B Jun 02 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 27 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B May 19 2014 
    Morning Coffee: Widely Held Guru Stocks Near Historic Low P/B May 12 2014 

    More From Other Websites
    Bio-Rad Announces U.S. FDA Pre-Market Approval for the BioPlex 2200 HIV Ag-Ab Assay, a Novel Next... Jul 28 2015
    Bio-Rad to Report Second-Quarter 2015 Financial Results Thursday, August 6, 2015 Jul 10 2015
    Bio-Rad's A1c Test Gets FDA Approval for Diabetes Detection - Analyst Blog Jun 10 2015
    Bio-Rad Announces FDA Clearance for Diagnosing Diabetes With Its VARIANT II TURBO HbA1c Kit - 2.0 Jun 09 2015
    Intrepid Capital’s Top Small-Cap Stocks: Tetra Tech Inc. (TTEK), Bio-Rad Laboratories Inc. (BIO),... May 15 2015
    Bio-Rad Laboratories, Inc. (BIO) Jumps: Stock Rises 6.2% - Tale of the Tape May 07 2015
    Bio-Rad posts 1Q profit May 05 2015
    Bio-Rad posts 1Q profit May 05 2015
    Bio-Rad Reports First-Quarter 2015 Financial Results May 05 2015
    Bio-Rad Grants Beckman Coulter Exclusive Distribution Rights for Access HIV and Hepatitis C Assays Apr 20 2015
    Bio-Rad to Report First-Quarter 2015 Financial Results Tuesday, May 5, 2015 Apr 15 2015
    Bio-Rad Extends Availability of Its Vitamin D Kit for the BioPlex 2200 System in the U.S. Apr 13 2015
    Bio-Rad Reports Fourth-Quarter and Full-Year 2014 Financial Results Feb 26 2015
    Bio-Rad to Report Fourth-Quarter and Full-Year 2014 Financial Results Thursday, February 26, 2015 Feb 03 2015
    Frost & Sullivan Recognizes Bio-Rad's Digital PCR Platform, the QX200™ AutoDG™ Droplet... Jan 28 2015
    Bio-Rad Receives Premarket Application Approval for Its Geenius HIV 1/2 Supplemental Assay Nov 18 2014
    Bio-Rad posts 3Q profit Nov 04 2014
    Bio-Rad posts 3Q profit Nov 04 2014
    Bio-Rad Reports Third-Quarter 2014 Financial Results Nov 04 2014
    Bio-Rad paying $55M to resolve US bribery claims Nov 03 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK